Increase in cases of diphtheria caused by C. diphtheriae in France in 2022
Update as of November 30, 2022, following reports of diphtheria caused by C. diphtheriae in several regions of mainland France, as well as in Mayotte and Réunion.
Diphtheria
thematic dossier
Diphtheria is caused by a bacterium that includes several species (Corynebacterium diphtheriae, C. ulcerans, C. pseudotuberculosis), some of which carry a gene responsible for the severity of the...
Since the beginning of 2022, several cases of diphtheria have been reported in nine regions of mainland France, as well as in Mayotte and Réunion. Compared to other years, the number of cases of C. diphtheriae is significantly higher than average. In mainland France, the majority of cases were reported among migrants and travelers. Thanks to very high vaccination coverage over many years, the occurrence of severe cases or clusters within the general population appears extremely low in mainland France and Réunion. In Mayotte, where vaccination coverage is insufficient, the bacterium has been circulating for several years.
Santé publique France is monitoring the evolving situation and the increase in diphtheria cases among migrants, the vast majority of whom are not up to date on their vaccinations. A reminder of vaccination and care recommendations has been sent to associations and healthcare professionals.
Overview of the Disease
Diphtheria, caused by Corynebacterium diphtheriae, is a highly contagious bacterial infection that spreads from person to person, primarily from sick individuals but also from healthy carriers (who may carry the bacteria for several weeks or months). Transmission occurs either directly via droplets or indirectly through contaminated objects (rare) or untreated skin lesions. The incubation period is short, less than 7 days (2 to 5 days). The disease presents as either an upper respiratory tract or skin infection.
Diphtheria is a notifiable disease.
Situation Update in France
As of November 30, 2022, 55 cases of diphtheria have been reported in France since the beginning of the year (Figure 1):
8 cases of diphtheria caused by Corynebacterium ulcerans (C. ulcerans) in mainland France;
30 cases of diphtheria caused by Corynebacterium diphtheriae (C. diphtheriae) in mainland France;
13 cases of diphtheria caused by C. diphtheriae in Mayotte and 4 in Réunion.
In 2022, compared to the previous 5 years, the number of C. ulcerans diphtheria cases was similar (an average of 7.2 cases per year), but the number of C. diphtheriae diphtheria cases was significantly higher than the average observed at that time (metropolitan France: 3.4 cases per year over the past 5 years; Mayotte: 2.6 cases per year over the past 5 years; Réunion: 0.6 cases per year over the past 5 years).
In mainland France
The majority of cases were reported among migrants (n=24) but also among travelers (n=5) (Figure 2). For these 29 cases, a link was found to one or more of the following countries: Afghanistan (n=21), Turkey (n=6), Italy (n=5), Serbia (n=5), Austria (n=4), Tunisia (n=3), Bulgaria (n=2), Iran (n=2), Hungary (n=2), Mali (n=2), Switzerland (n=2), Slovenia (n=1), Syria (n=1), Senegal (n=1), Thailand (n=1). When the date of their arrival in France was known (n=9), it was less than 15 days prior to the date of disease notification.
Furthermore, one case was likely infected on French soil through contact with a person returning from a trip to Togo.
Cases of diphtheria caused by C. diphtheriae were predominantly men (n=28), aged 11 to 47 years (average age 21). Only two of them were up to date on their diphtheria vaccinations. For 24 of them, vaccination status was unknown.
Among the cases occurring in migrants, 6 were residing in shelters.
Cases were diagnosed in 9 regions. The Normandy region was the most affected, with 7 reported cases (Figure 3). Twenty-five cases were cutaneous forms, 3 were asymptomatic carriers (in the oropharynx), one was a mildly symptomatic respiratory form (autochthonous case), and another presented with symptoms of classic respiratory diphtheria (migrant).
Two clusters were reported: one involved 4 cases who had traveled together on a bus, and the other involved two cases who had traveled together.
Genotyping of 19 isolates by the National Reference Center (NRC) for Corynebacteria of the diphtheriae complex via genomic sequencing revealed 5 distinct genetic groups: ST377a (2 cases), ST377b (1 case), ST384 (2 cases), ST574 (3 cases), ST698 (2 cases). These groups have also been identified in other European countries. The remaining isolates are currently being sequenced.
This increase in the number of cases among migrants is also being observed in other European countries. As of September 26, 2022, the European Centre for Disease Prevention and Control (ECDC) reported 92 cases of diphtheria caused by C. diphtheriae in 2022 across seven European countries (Germany, Austria, Belgium, France, Great Britain, Norway, and Switzerland)
Mayotte and Réunion
In Mayotte, local circulation of the bacterium has been known for several years. In 2022, of the 13 reported cases, 7 were cutaneous forms, 1 was an ENT form, and 5 were asymptomatic carriers (ENT) of the bacterium. These last 5 infections were detected among close contacts of 2 symptomatic cases. One death occurred in an unvaccinated 7-month-old infant.
In Réunion, during the 2021–2022 period, all reported cases were imported cases. In 2022, 4 cases were reported, and no travel history was identified. These 4 cases were apparently unrelated and were cutaneous forms.
Genomic clustering analysis by the CNR showed that 12 strains (8 in Mayotte and 4 in Réunion) shared the same characteristics, strongly suggesting that these cases are linked. We have no hypothesis at this stage regarding the nature of this link.
What measures have been put in place?
In mainland France and Réunion
France has very high vaccination coverage (VC) against diphtheria: 99% for the primary vaccination and 96% for the 11-month booster among infants in 2019. These vaccination coverage rates have been very high for many years, as the vaccine was mandatory up to age 13 until 2018. Furthermore, vaccination is mandatory for infants born in 2018 or later. The risk of cases occurring, particularly severe cases and/or clusters within the general French population, therefore remains extremely low.
In Réunion, vaccination coverage is also high (97.4% for the 11-month booster in 2018). However, the increase in diphtheria cases among migrants—the vast majority of whom are not up to date on their vaccinations—raises concerns about the emergence of clusters of C. diphtheriae infection in shelters for migrants, refugees, or asylum seekers (this scenario has been described in Switzerland, Kofler et al. Eurosurveillance 2022). To prevent this risk, a notice1 informing about this increase in cases among migrants and reiterating vaccination and management recommendations2 was sent to organizations supporting migrant populations and to healthcare professionals.
Investigations and discussions regarding cases occurring among migrants are being conducted at the European level (ECDC and WHO), particularly to identify a potential source of infection (countries traversed along the migration route or countries of origin such as Afghanistan).
In Mayotte
In Mayotte, studies conducted in recent years show insufficient vaccination coverage to ensure herd immunity. In 2019, 93.2% of children aged 24 to 59 months; 45.3% of 7- to 11-year-olds; and 27.1% of 14- to 16-year-olds were up to date on their diphtheria vaccinations. Efforts to increase vaccination coverage in these populations must be strengthened in this territory.
1- MINSANTE No. 2022_66 dated September 27, 2022
2- Opinion of the High Council for Public Health regarding the appropriate course of action in the event of a diphtheria case, dated March 4, 2011, and supplement dated September 10, 2022: https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=215
Vaccination Information Service
What are vaccines for? How do they work? At what age should children be vaccinated? Vaccination-info-service.fr answers the most frequently asked questions about vaccination. A separate...